Jacob Ross
University College London
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jacob Ross.
Stem Cells | 2012
Jacob Ross; Abigail Benn; Jacqueline Jonuschies; Luisa Boldrin; Francesco Muntoni; Jane E. Hewitt; Susan C. Brown; Jennifer E. Morgan
The dystrophin‐associated glycoprotein complex (DGC) is found at the muscle fiber sarcolemma and forms an essential structural link between the basal lamina and internal cytoskeleton. In a set of muscular dystrophies known as the dystroglycanopathies, hypoglycosylation of the DGC component α‐dystroglycan results in reduced binding to basal lamina components, a loss in structural stability, and repeated cycles of muscle fiber degeneration and regeneration. The satellite cells are the key stem cells responsible for muscle repair and reside between the basal lamina and sarcolemma. In this study, we aimed to determine whether pathological changes associated with the dystroglycanopathies affect satellite cell function. In the Largemyd mouse dystroglycanopathy model, satellite cells are present in significantly greater numbers but display reduced proliferation on their native muscle fibers in vitro, compared with wild type. However, when removed from their fiber, proliferation in culture is restored to that of wild type. Immunohistochemical analysis of Largemyd muscle reveals alterations to the basal lamina and interstitium, including marked disorganization of laminin, upregulation of fibronectin and collagens. Proliferation and differentiation of wild‐type satellite cells is impaired when cultured on substrates such as collagen and fibronectin, compared with laminins. When engrafted into irradiated tibialis anterior muscles of mdx‐nude mice, wild‐type satellite cells expanded on laminin contribute significantly more to muscle regeneration than those expanded on fibronectin. These results suggest that defects in α‐dystroglycan glycosylation are associated with an alteration in the satellite cell niche, and that regenerative potential in the dystroglycanopathies may be perturbed. STEM Cells2012;30:2330–2341
Gastroenterology | 2012
Jacob Ross; Ermanno Gherardi; Noemi Mallorqui–Fernandez; Marco Bocci; Anna Sobkowicz; Myrrdin Rees; Arthur J. Rowe; Stephan Ellmerich; Isobel Massie; Junpei Soeda; Clare Selden; Humphrey Hodgson
BACKGROUND & AIMS Hepatocyte growth factor/scatter factor (HGF/SF) stimulates hepatocyte DNA synthesis and protects against apoptosis; in vivo it promotes liver regeneration and reduces fibrosis. However, its therapeutic value is limited by its complex domain structure, high cost of production, instability, and poor tissue penetration due to sequestration by heparin sulfate proteoglycans (HSPGs). METHODS Using protein engineering techniques, we created a full-length form of HGF/SF (called HP21) and a form of the small, naturally occurring HGF/SF fragment, NK1 (called 1K1), which have reduced affinity for HSPG. We characterized the stability and proliferative and anti-apoptotic effects of these variants in primary human hepatocytes and in rodents. RESULTS Analytical ultracentrifugation showed that 1K1 and NK1 were more stable than the native, full-length protein. All 4 forms of HGF/SF induced similar levels of DNA synthesis in human hepatocytes; 1K1 and NK1 required heparin, an HSPG analogue, for full agonistic activity. All the proteins reduced levels of Fas ligand-mediated apoptosis, reducing the activity of caspase-3/7 and cleavage of poly(adenosine diphosphate-ribose) polymerase. 1K1 was more active than NK1 in rodents; in healthy mice, 1K1 significantly increased hepatocyte DNA synthesis, and in mice receiving carbon tetrachloride, it reduced fibrosis. In rats, after 70% partial hepatectomy, daily administration of 1K1 for 5 days significantly increased liver mass and the bromodeoxyuridine labeling index compared with mice given NK1. CONCLUSIONS 1K1, an engineered form of the small, naturally occurring HGF/SF fragment NK1, has reduced affinity for HSPG and exerts proliferative and antiapoptotic effects in cultured hepatocytes. In rodents, 1K1 has antifibrotic effects and promotes liver regeneration. The protein has better stability and is easier to produce than HGF/SF and might be developed as a therapeutic for acute and chronic liver disease.
Journal of Cell Science | 2017
Jacob Ross; Richard Webster; Tanguy Lechertier; Louise E. Reynolds; Mark Turmaine; Maximilien Bencze; Yalda Jamshidi; Hakan Cetin; Francesco Muntoni; David Beeson; Kairbaan Hodilvala-Dilke; Francesco J. Conti
ABSTRACT The neuromuscular junction (NMJ) is the synapse between motoneurons and skeletal muscle, and is responsible for eliciting muscle contraction. Neurotransmission at synapses depends on the release of synaptic vesicles at sites called active zones (AZs). Various proteins of the extracellular matrix are crucial for NMJ development; however, little is known about the identity and functions of the receptors that mediate their effects. Using genetically modified mice, we find that integrin-α3 (encoded by Itga3), an adhesion receptor at the presynaptic membrane, is involved in the localisation of AZ components and efficient synaptic vesicle release. Integrin-α3 also regulates integrity of the synapse – mutant NMJs present with progressive structural changes and upregulated autophagy, features commonly observed during ageing and in models of neurodegeneration. Unexpectedly, we find instances of nerve terminal detachment from the muscle fibre; to our knowledge, this is the first report of a receptor that is required for the physical anchorage of pre- and postsynaptic elements at the NMJ. These results demonstrate multiple roles of integrin-α3 at the NMJ, and suggest that alterations in its function could underlie defects that occur in neurodegeneration or ageing. Summary: Adhesion receptor integrin-α3 is involved in presynaptic differentiation, synaptic maintenance and nerve terminal anchorage at the neuromuscular synapse.
Scientific Reports | 2017
Luisa Boldrin; Jacob Ross; Charlotte Whitmore; Bruno Doreste; Charlotte M. Beaver; Ayad Eddaoudi; Daniel J. Pearce; Jennifer E. Morgan
Loss of skeletal muscle mass and function occurs with increasing age. Calorie restriction (CR) increases the lifespan of C57Bl/6 mice, but not in the shorter-lived DBA/2 strain. There is some evidence that calorie restriction reduces or delays many of the age-related defects that occur in rodent skeletal muscle. We therefore investigated the effect of short (2.5 month) and longer term (8.5 and 18.5 months) CR on skeletal muscle in male and female C57Bl/6 and DBA/2 mice. We found that short-term CR increased the satellite cell number and collagen VI content of muscle, but resulted in a delayed regenerative response to injury.Consistent with this, the in vitro proliferation of satellite cells derived from these muscles was reduced by CR. The percentage of stromal cells, macrophages, hematopoietic stem cells and fibroadipogenic cells in the mononucleated cell population derived from skeletal muscle was reduced by CR at various stages. But overall, these changes are neither consistent over time, nor between strain and sex. The fact that changes induced by CR do not persist with time and the dissimilarities between the two mouse strains, combined with sex differences, urge caution in applying CR to improve skeletal muscle function across the lifespan in humans.
Neuromuscular Disorders | 2012
Jacob Ross; Tanguy Lechertier; Jennifer E. Morgan; Francesco Muntoni; Kairbaan Hodivala-Dilke; Francesco J. Conti
P14 Roles of a3-integrin in development of the neuromuscular system J. Ross, T. Lechertier, J. Morgan, F. Muntoni, K. Hodivala-Dilke, F. Conti. Dubowitz Neuromuscular Centre, Institute of Child Health, University College London, 30 Guilford St, London WC1N 1EH, UK; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK
Cryobiology | 2010
Isobel Massie; Jacob Ross; Noemi Mallorqui-Fernandez; Ermanno Gherardi; Humphrey Hodgson; Clare Selden; Barry J. Fuller
Development | 2017
Jacob Ross; Richard Webster; Tanguy Lechertier; Louise E. Reynolds; Mark Turmaine; Maximilien Bencze; Yalda Jamshidi; Hakan Cetin; Francesco Muntoni; David Beeson; Kairbaan Hodilvala-Dilke; Francesco J. Conti
Neuromuscular Disorders | 2014
Jacob Ross; R. Webster; Tanguy Lechertier; Louise E. Reynolds; Francesco Muntoni; David Beeson; Kairbaan Hodivala-Dilke; Francesco J. Conti
Archive | 2012
Jacob Ross; Ermanno Gherardi; Marco Bocci; Anna Sobkowicz; Myrrdin Rees; Arthur J. Rowe; Stephan Ellmerich; Isobel Massie; Junpei Soeda; Clare Selden; H. J. F. Hodgson
In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S11-S11). PERGAMON-ELSEVIER SCIENCE LTD (2012) | 2012
Jacob Ross; Tanguy Lechertier; J Morgan; Francesco Muntoni; Kairbaan Hodivala-Dilke; Francesco J. Conti